Palvella Therapeutics Inc (PVLA)
$24.43 -2.54 (-9.42%)| Market Cap | 297.18M |
| Revenue (ttm) | 42.81M |
| Net Income (ttm) | -24.54M |
| EPS (ttm) | N/A |
| PE Ratio | 0.00 |
| Forward PE | N/A |
| Profit Margin | -57.32% |
| Debt to Equity Ratio | 0.00 |
| Volume | 79,800 |
| Avg Vol | 66,968 |
| Day's Range | N/A - N/A |
| Shares Out | 11.02M |
| Stochastic %K | 3% |
| Beta | 0.10 |
| Analysts | Strong Sell |
| Price Target | $47.28 |
Latest News on PVLA
Apr 2, 2025, 8:00 AM EDT - 2 days ago
Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology
Mar 31, 2025, 7:30 AM EDT - 4 days ago
Palvella Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
Mar 18, 2025, 8:30 AM EDT - 17 days ago
Palvella Therapeutics to Host Full Year 2024 Financial Results Conference Call on March 31, 2025
Feb 25, 2025, 8:00 AM EST - 5 weeks ago
Palvella Therapeutics to Present at the TD Cowen 45th Annual Healthcare Conference
Dec 13, 2024, 2:55 PM EST - 3 months ago
Palvella Therapeutics Announces Closing of Merger with Pieris Pharmaceuticals and Concurrent Private Placement of $78.9 Million